Day One Biopharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Day One Biopharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker DAWN.
Operating as a clinical-stage biopharmaceutical entity, Day One Biopharmaceuticals, Inc. is dedicated to discovering and commercializing precise therapeutic options for individuals battling genetically defined cancers. A key asset is DAY101, an orally administered, brain-permeable type II pan-rapidly accelerated fibrosarcoma kinase inhibitor, currently undergoing Phase II clinical trials for young patients...
Can you invest in Day One Biopharmaceuticals, Inc.?
Yes. Day One Biopharmaceuticals, Inc. trades publicly on NASDAQ as DAWN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Day One Biopharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.